The global Medical Robots market size was USD 26.8 billion in 2023, and is calculated at USD 31.11 Billion in 2024. The market is projected to reach USD 145.7 Billion by 2034, and register a revenue 15.2% over the forecast period (2025-2034).

Premium Insights:

The global medical robots market growth is driven by significant transformation in approaches in the healthcare sector and industry, as well as rapid technological advancements, rising demand for minimally invasive surgeries, and increasing automation of operations and streamlining of the overall healthcare approach and functioning. Medical robots are revolutionizing healthcare by enhancing precision, reducing human error, and facilitating improved patient outcomes in various medical applications. These robots range from surgical assistants and rehabilitation robots to diagnostics, disinfection robots, and numerous others. Growth of this market is also supported to a major extent by a blend of technological innovation, increased healthcare spending, and rapid and increasing acceptance of robotics in medical practice and operations. Emergence of a wide range of surgical robots, rehabilitation robots, hospital & pharmacy automation robots, non-invasive radiosurgery robots, and other application-specific robots continue to drive innovation and open up new avenues for application in the healthcare sector, and this ongoing trend is expected to continue to support growth of the medical robots market over the forecast period.

The benefits and advantages offered including surgical precision, healthcare automation, and AI-assisted technologies in medical procedures are being recognized and this is also supporting increased investments, by private and government entities, to further advancements and drive innovations in the healthcare sector. Among the various solutions, surgical robots are registering fastest adoption, especially for performing minimally invasive procedures with enhanced accuracy. Rehabilitation and assistive robots, pharmacy automation, and hospital automation robots are also expected to see increased adoption rates due to rising focus on streamlining healthcare operations and ensuring better patient outcomes.

{{bar_graph}}

Top Medical Robots Market Drivers and Trends:

• Technological Advancements in Robotics and AI Integration: Continuous innovations in robotics technology, particularly in Artificial Intelligence (AI), Machine Learning (ML), and sensory capabilities, are enabling medical robots to perform increasingly more complex procedures with enhanced precision and reliability. AI-powered surgical robots, for example, assist in procedures like minimally invasive surgeries by providing better visualization and control. Also, robots are increasingly able to learn and adapt from surgical data, improving outcomes over time and driving market demand.
• Growing Preference for Minimally Invasive and Precision Surgery: Significant shift towards minimally invasive surgeries, which offer faster recovery, less pain, and reduced hospital stays is a major factor driving market growth. Medical robots facilitate these procedures by providing greater dexterity and accuracy, making them ideal for complex and delicate surgeries, such as cardiac, orthopedic, and neurosurgical operations. As healthcare providers recognize these benefits, demand for medical robots is expected to continue to rise steadily over the forecast period.
• Aging Population and Rising Incidence of Chronic Diseases: The rapidly aging global aging global population and increasing prevalence of chronic diseases and conditions, such as cardiovascular and orthopedic issues, is another key factor expected to continue to support revenue growth of the market. Age-related conditions and medical needs are leading to a steady incline in number of individuals approaching healthcare facilities for treatment and care. This includes need for surgical interventions and rehabilitation, where robotic assistance is crucial. In particular, use of and demand for rehabilitation robots and exoskeletons has been increasing in elderly care, and the trend is expected to gain momentum.​
• Supportive Government Policies and Increased R&D Investments: Government initiatives promoting healthcare modernization and funding for medical technology research are contributing to growth of the medical robots market. This is particularly robust in markets such as the US, China, and countries in Europe. Regulatory bodies have been encouraging development of robotic technologies and solutions, while companies continue to invest substantially in R&D to innovate and customize solutions for various medical applications. These policies create a favorable environment for the integration of robotics in hospitals and clinics, thereby increasing accessibility and adoption.

Medical Robots Market Restraining Factor Insights

• High Costs and Limited Affordability: Substantially high upfront cost for purchasing and installing medical robots, along with ongoing maintenance expenses, presents a significant barrier for many healthcare providers, particularly smaller hospitals and clinics. These systems often require specialized equipment and training, leading to increased financial and operational burdens. As a result, only well-funded hospitals can afford these technologies, thus restricting wider adoption and limiting market penetration​.
• Technical and Operational Complexity: Medical robots require skilled personnel for operation and maintenance, which adds to the costs and creates logistical challenges in facilities lacking trained staff. The learning curve associated with robotic systems can lead to slow adoption, as surgeons and healthcare workers may be hesitant to transition to robotic-assisted procedures. Also, the technical complexity raises concerns about malfunction risks during critical procedures, which can deter adoption due to safety concerns​.
• Regulatory and Ethical Challenges: Stringent regulatory environment around medical devices can slow the approval and commercialization of new robotic systems. In some regions, regulatory frameworks are complex and inconsistent, resulting in longer timeframes for market entry. Ethical concerns about replacing human roles and fears over AI-driven decision-making in healthcare create public resistance, which can further impact the adoption and demand for these technologies. Uncertainties about liability in case of errors also complicate regulatory compliance and hinder market expansion.

Medical Robots Market Opportunities

• Expansion into Emerging Markets: Manufacturers can target emerging markets such as India, China, and Latin America, where the demand for advanced medical technology is increasing. These regions are seeing rapid healthcare infrastructure development and a growing middle class that can support higher investments in medical robotics. Companies can develop affordable, cost-effective solutions tailored to local needs and regulatory environments, tapping into the rising demand for surgical robots and rehabilitation technologies.
• New Product Development and Innovation: Companies can increase revenue by investing in the development of new robotic systems for untapped medical applications, such as robotic rehabilitation for stroke patients or robots for complex neuro-surgeries. By advancing existing platforms and incorporating AI and machine learning, manufacturers can offer systems that provide better precision, data analytics, and patient outcomes, catering to new niches in healthcare​.
• Strategic Partnerships, Mergers, and Acquisitions: Forming joint ventures, partnerships, and acquisitions of emerging tech companies can allow leading players to accelerate product development and expand their service offerings. For example, acquiring AI-driven companies or partnering with healthcare providers can improve robotic capabilities and integration of systems and solutions, thereby increasing the value of offerings​.

{{dialog}}

Medical Robots Market Segmentation:

By Product Type:

• Surgical Robots
• Rehabilitation Robots
• Non-invasive Radiosurgery Robots
• Hospital and Pharmacy Robots
• Other Types

By Component:

• Robotic Systems
• Software & AI Modules
• Sensors & Actuators
• Power & Control Systems
• End Effectors & Accessories
• Services

By Application:

• Laparoscopy
• Orthopedics
• Neurosurgery
• Urology
• Cardiology
• Gynecology
• Rehabilitation
• Pharmacy & Laboratory Applications
• Diagnostic Imaging
• Others

By End-User:

• Hospitals
• Ambulatory Surgery Centers (ASCs)
• Rehabilitation Centers
• Specialty Clinics
• Pharmacy & Laboratory Facilities
• Research Institutes

Segment Insights:

By Product Type:

The surgical robots segment is expected to register fastest revenue growth rate and account for largest revenue share over the forecast period. This projected dominance can be attributed to increasing preference for minimally invasive surgical procedures increasing designing, training, and use of new and more advanced surgical robots to perform surgeries and medical procedures with high level of accuracy and precision, thereby minimizing surgical complications, reducing recovery times, and improving patient outcomes. Robotic-assisted surgeries have become popular in fields like orthopedics, urology, and cardiology due to ability of artificial intelligence-driven systems and robotics to deliver improved patient outcomes and lower healthcare costs over time​. In addition, major players in this market such as Intuitive Surgical, with its Da Vinci Surgical System, and Stryker, known for its Mako System, continue to innovate and expand the capabilities of their robotic platforms, which is only expected to further enhance capabilities of these systems over time. Furthermore, rising investments in robotic surgery and technological advancements, including AI integration, further supports the projected largest revenue share and fastest growth rate of this segment.

By Component:

Among the component segments, the robotic systems segment is expected to account for largest revenue share over the forecast period. The primary factors supporting this projection are high cost and complexity associated with these core components. Robotic systems, such as those used in surgery or rehabilitation, comprise sophisticated machinery, sensors, and software that together drive the high initial investment. Moreover, as healthcare providers continue adopting these systems, maintenance and updates are crucial, creating a recurring revenue stream and further enhancing the value of the robotic systems segment within the market​

By Application:

Among the application segments, the laparoscopy segment is expected to account for largest revenue share over the forecast period. Involving minimally invasive surgery, laparoscopic procedures benefit greatly from robotic assistance, as the robots improve visibility, reduce surgeon fatigue, and offer greater dexterity than traditional techniques. This adoption is further accelerated by the increase in bariatric, gynecological, and gastrointestinal surgeries, where the precision offered by robots proves highly valuable. In addition, companies are focusing on creating specific tools and systems specifically for these procedures, which will further position laparoscopy as a leading application in the medical robots market​.

{{dashboard_image}}

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

By End-User:

Among the end-user segments, the hospitals segment is expected to account for largest revenue share over the forecast period. Hospitals are the primary settings for surgical procedures, diagnostic imaging, and rehabilitation. Also, hospitals are expected to continue to account for largest adoption volumes and adoption rates of medical robots as these solutions are being widely integrated into the healthcare sector to enhance operational efficiency, especially in high-demand and specialized departments. Robotic systems allow for improved patient outcomes while optimizing workflows, which is particularly important in large hospital networks facing staffing shortages. In addition, financial capacity of hospitals to invest in advanced robotic technology is a major factor expected to continue to contribute to growth of this segment​.

Regions and Countries

North America

• United States
• Canada
• Mexico
  

Europe

• Germany
• United Kingdom
• France
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India

Rest of Asia Pacific

• Latin America
• Brazil
• Argentina

Rest of Latin America

• Middle East & Africa
• Saudi Arabia
• South Africa
• United Arab Emirates
• Israel
• Rest of MEA

Medical Robots Market Regional Landscape:

Among the regional markets in 2023, North America accounted for largest revenue share, driven by substantial investment in medical technologies and devices, including AI, ML, and robots and robotics, early adoption of new and advanced technologies and solutions, and presence of major companies in countries in the region. The US particularly, is headquarters to a number of industry giants such as Intuitive Surgical (Da Vinci Surgical System) and Medtronic, both of which are headquartered in the country. Also, these companies are engaged in continuous advances and innovations and actively expanding robotic systems tailored to US healthcare demands. Strong regulatory frameworks and FDA approvals for medical robotics have also accelerated adoption. In addition, the US continues to record consistent growth in robotic-assisted surgeries, especially in orthopedics and cardiology, as healthcare providers explore ways to enhance surgical precision and efficiency​.

In Europe, Germany, the UK, and France lead in terms of strong revenue share and adoption of medical robots, supported by government initiatives and high healthcare standards. Germany is particularly appreciated for its robust healthcare funding and adoption of robots in complex surgeries.Companies such as Siemens Healthineers (Germany) and Smith & Nephew (UK) operate prominently in the Europe market, developing robotics that comply with stringent EU medical regulations. Also, the EU’s Medical Device Regulation (MDR) encourages high-quality robotics solutions, enhancing safety standards and promoting robotic technology across hospitals and specialized clinics.​

Asia Pacific is registering moderate incline in revenue growth, led by China, Japan, and South Korea. Rising healthcare spending, significant elderly populations, and increasing demand for surgical precision are key factors driving steady incline in adoption of robotic systems. Companies in China are developing robots suited to local needs, with government support under the ‘Made in China 2025’ initiative prioritizing domestic medical technology innovation adding momentum to development and innovation. In Japan, robotics companies such as Cyberdyne and ReWalk Robotics are at the forefront of rehabilitation robotics, catering to Japan’s aging population and focusing on assisted mobility and rehabilitation​.

In Latin America, Brazil and Mexico are the primary markets, supported by rising private healthcare investments driving adoption of medical robotics and systems. This is currently limited by high costs however, but is expected to gain traction with indications of collaborations with firms in North America expected to stimulate medical tourism over the forecast period.

In the Middle East and Africa, adoption of medical robots is slow, but is progressing in the right direction. This is especially indicative in the UAE and South Africa, where healthcare infrastructure investments are enabling robotic technologies. Also, government initiatives aimed at advancing medical technology are encouraging robotics adoption to enhance healthcare service quality.

Medical Robots Market Competitive Landscape:

Company List:

• Intuitive Surgical, Inc.
• Stryker Corporation
• Medtronic plc
• Zimmer Biomet Holdings, Inc.
• Smith & Nephew plc
• Siemens Healthineers AG
• Johnson & Johnson (Verb Surgical)
• Ekso Bionics Holdings, Inc.
• ReWalk Robotics Ltd.
• Cyberdyne Inc.
• ARxIUM
• Omnicell, Inc.
• TransEnterix, Inc.
• Accuray Incorporated
• Hocoma AG

Competitive Landscape:

The competitive landscape in the global medical robots market is highly dynamic, characterized by a blend of established players and innovative new entrants. Leading companies, such as Intuitive Surgical, Medtronic, Stryker, and Siemens Healthineers, are implementing strategic measures to strengthen their market position and expand their consumer base. One primary strategy is mergers and acquisitions; for example, Medtronic’s acquisition of Mazor Robotics added a renowned spinal surgery platform to its portfolio, reinforcing its foothold in orthopedic robotics​. Similarly, Johnson & Johnson acquired Auris Health to enhance its capabilities in lung cancer diagnostics and expand its surgical robotics offerings. Another key strategy is partnerships and collaborations with technology firms and healthcare providers. Companies are increasingly teaming up with AI specialists to enhance the intelligence of robotic systems, enabling real-time data analysis and decision-making. For instance, Stryker has collaborated with AI and software companies to improve the precision and accuracy of its robotic arm-assisted surgery system, Mako​.

A number of companies are tailoring products to local market needs, especially in regions like Asia Pacific, where the demand for cost-effective, versatile robots is high. In addition, product innovation remains central to maintaining market leadership. Companies invest significantly in R&D to develop next-generation robots, such as soft-tissue surgical robots and multi-functional diagnostic robots, which meet evolving healthcare needs. This focus on diversified solutions, coupled with regulatory compliance efforts, is helping leading companies remain competitive and cater to a growing global consumer base​

Recent Developments

• September 5, 2024: Medtronic plc, which is a leading company in healthcare technology, has expanded its Medtronic Customer eXperience Center (MCXC) in Singapore by launching the regions first Robotics Experience Studio in Southeast Asia. This development highlights Medtronics dedication to improving access to advanced healthcare technologies through collaboration, education, and training within the healthcare community, and also aims to enhance the Centres of Excellence at Sunway Medical Centre, which is a private quaternary hospital in Malaysia, with a focus on spine, neuroscience, and cardiovascular medicine. In addition, advanced robotic surgical techniques will be tested in a clinical setting as part of this partnership.
• February 22, 2024: Zimmer Biomet Holdings, Inc., which is an innovative leader in medical technology, announced it has secured clearance from the U.S. ​Food and Drug Administration (FDA) for its ROSA Shoulder System, designed for robotic-assisted shoulder replacement procedures.​ This groundbreaking system is recognized as the first of its kind for shoulder replacement surgery, marking the fourth addition to the companys extensive ROSA Robotics portfolio, which also features the ROSA Knee System for total knee arthroplasty and the ROSA Hip System for total hip replacements. The ROSA Shoulder is designed to provide surgeons with versatility to perform total shoulder replacements using either anatomic or reverse methods, facilitating accurate placement that contributes to better surgical outcomes.

Frequently Asked Questions:

Q: What is the global medical robots market size in 2024 and what is the projection for 2034?

A: The global medical robots market size was calculated at USD 31.11 billion in 2024 and expected to reach USD 138.45 billion in 2034

Which regional market accounted for largest revenue share in 2023, and what is the expected trend over the forecast period?

A: North America is expected to account for largest revenue share in the global market over the forecast period.

Q: Which are the major companies are included in the global medical robots market report?

A: Major companies in the market report are Intuitive Surgical, Inc., Stryker Corporation, Medtronic plc, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Siemens Healthineers AG, Johnson & Johnson (through Verb Surgical), Ekso Bionics Holdings, Inc., ReWalk Robotics Ltd., Cyberdyne Inc., ARxIUM, Omnicell, Inc., TransEnterix, Inc. (Asensus Surgical), Accuray Incorporated, Hocoma AG (subsidiary of DIH International).

Q: What is the projected revenue CAGR of the global medical robots market over the forecast period?

A: The global Medical Robots Market is expected to register a CAGR of 16.1% between 2025 and 2034.

Q: What are some key factors driving revenue growth of the medical robots market ?

A: Some key factors driving market revenue growths are significant transformation in approaches in the healthcare sector and industry, as well as rapid technological advancements, rising demand for minimally invasive surgeries, and increasing automation of operations and streamlining of the overall healthcare approach and functioning.

Meta Description:

global medical robots market size is calculated at USD 31.11 billion in 2024, and will reach USD 138.45 billion in 2034, and register CAGR of 16.1%

Primary Keywords

Medical Robots Market

Revenue Growth

Surgical Robots

Rehabilitation Robots

Healthcare Automation

Minimally Invasive Surgeries

Robotic Systems

Diagnostic Robots

AI and ML

Medical Robotics Technology

Secondary Keywords:

Therapeutic Robots

Assistive Robots

Exoskeleton

Prosthetic

Hospital Automation Robots

Non-Invasive Radiosurgery Robots

Laparoscopy

Orthopedic Robotics

Neurosurgery Robotics

Urology Robotics

Cardiology Robotics

Gynecological Surgery Robots

Rehabilitation Applications